Table 3.
Univariate and multivariate linear regression analysis with aortic TBRmax as the dependent variable
| Characteristic | Univariate Analyses | Multivariate Analysesa | ||
|---|---|---|---|---|
| β (95% CI) | P Value | β (95% CI) | P Value | |
| Urea | 0.51 (−0.01 to 0.18) | 0.08 | 0.82 (0.01 to 0.26) | 0.04 |
| Creatinine | 0.36 (−0.01 to 0.01) | 0.23 | 0.85 (0.00 to 0.02) | 0.05 |
| eGFR (CKD-EPI) | −0.40 (−0.06 to 0.01) | 0.18 | −0.08 (−0.09 to 0.00) | 0.05 |
| SBP | 0.61 (0.01 to 0.05) | 0.04 | 0.86 (−0.01 to 0.07) | 0.06 |
| LDL cholesterol | −0.01 (−0.45 to 0.44) | 1.00 | −0.09 (−0.69 to 0.57) | 0.84 |
| HDL cholesterol | −0.10 (−1.84 to 1.35) | 0.75 | −0.13 (−2.25 to 1.63) | 0.73 |
| TG | −0.16 (−1.34 to 0.82) | 0.61 | −0.22 (−1.73 to 1.01) | 0.56 |
| CRP | −0.10 (−0.14 to 0.10) | 0.74 | −0.01 (−0.21 to 0.21) | 0.98 |
Data are standardized coefficient (β) with 95% confidence intervals (95% CI). CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; SBP, systolic BP; TG, triglycerides.
a
BMI, current smoking status, and statin use were used as covariates.